Primary study · included by 1 review

Hettiarachchi 2017

ProbableThe reviews cited this study without a PMID, DOI or NCT, so it is matched by first author and year. Two different studies by the same author in the same year could be merged here.

Included by

Evaluating calcineurin inhibitors as alternatives to steroids in treating Oral Lichen Planus: a systematic review and meta-analysis.

Non-Cochrane · intervention · 2026 · cited as Hettiarachchi 2017 · Supplementary Table 1; Figures 2, 5, 6

Outcome this study informs	Pooled effect	Evidence	Certainty
Lesion morphology (Clinical Score 0-5) Topical calcineurin inhibitors (tacrolimus, pimecrolimus, cyclosporin) vs Topical steroids (clobetasol, betamethasone, triamcinolone) · 4 weeks	MD -0.08 [-0.74, 0.57]	3 studies · 158 participants	Moderate
Pain severity (VAS 0-10) Topical calcineurin inhibitors (tacrolimus, pimecrolimus, cyclosporin) vs Topical steroids (clobetasol, betamethasone, triamcinolone) · 4 weeks (follow-up weeks 3-4)	MD -0.06 [-0.55, 0.44]	5 studies · 276 participants	Moderate
Pain severity (VAS 0-10) Topical calcineurin inhibitors (tacrolimus, pimecrolimus, cyclosporin) vs Topical steroids (clobetasol, betamethasone, triamcinolone) · 4 weeks	MD -0.11 [-0.97, 0.62]	5 studies · 275 participants	GRADE not reported

1 including review in total.